INS and Alzheimer disease: On the other hand, discrepant plasma AA profiles in previous studies should not be surprising because the metabolic conditions of AD patients may be greatly heterogeneous as they are dependent not only on biochemical alterations due to Aβ deposition [37] but also on patients’ protein intake, body muscle proteolysis [38], insulin resistance [17], and severe muscle and brain metabolic derangements [37].